Moloney Securities Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $771K | Sell |
|
|||||
|
2025
Q1 | $1.21M | Buy |
|
|||||
|
2024
Q4 | $843K | Sell |
|
|||||
|
2024
Q3 | $1.29M | Sell |
|
|||||
|
2024
Q2 | $2.13M | Buy |
|
|||||
|
2024
Q1 | $1.66M | Buy |
|
|||||
|
2023
Q4 | $1.25M | Sell |
|
|||||
|
2023
Q3 | $1.11M | Sell |
|
|||||
|
2023
Q2 | $1.03M | Buy |
|
|||||
|
2023
Q1 | $1.01M | Sell |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $760K | Sell |
|
|||||
|
2022
Q2 | $967K | Sell |
|
|||||
|
2022
Q1 | $986K | Buy |
|
|||||
|
2021
Q4 | $980K | Sell |
|
|||||
|
2021
Q3 | $859K | Sell |
|
|||||
|
2021
Q2 | $888K | Hold |
|
|||||
|
2021
Q1 | $715K | Sell |
|
|||||
|
2020
Q4 | $747K | Sell |
|
|||||
|
2020
Q3 | $760K | Hold |
|
|||||
|
2020
Q2 | $716K | Sell |
|
|||||
|
2020
Q1 | $679K | Sell |
|
|||||
|
2019
Q4 | $664K | Hold |
|
|||||
|
2019
Q3 | $593K | Sell |
|
|||||
|
2019
Q2 | $600K | Buy |
|
|||||
|
2019
Q1 | $597K | Sell |
|
|||||
|
2018
Q4 | $587K | Hold |
|
|||||
|
2018
Q3 | $601K | Buy |
|
|||||
|
2018
Q2 | $583K | Sell |
|
|||||
|
2018
Q1 | $729K | Sell |
|
|||||
|
2017
Q4 | $869K | Sell |
|
|||||
|
2017
Q3 | $895K | Sell |
|
|||||
|
2017
Q2 | $827K | Buy |
|
|||||
|
2017
Q1 | $626K | Sell |
|
|||||
|
2016
Q4 | $992K | Buy |
|